RoMEA Newborn Screening Market to 2032
Overview
The RoMEA Newborn Screening Market is expected to reach a 54.28 USD Billion by 2032 and is projected to grow at a CAGR of 10.91% from 2025 to 2032.
Revenue, 2024 (USD Billion)
28.50
Forecast, 2032 (USD Billion)
54.28
CAGR, 2024 - 2032
10.91%
Report Coverage
RoMEA
RoMEA Newborn Screening Market 2018-2032 USD Billion
RoMEA Newborn Screening Market , Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 28.50 USD Billion
- Projected Market Size (2032): 54.28 USD Billion
- CAGR (2025-2032): 10.91%
Key Findings of RoMEA Newborn Screening Market
- The RoMEA Newborn Screening Market was valued at 28.50 USD Billion in 2024.
- The RoMEA Newborn Screening Market is likely to grow at a CAGR of 10.91% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Hospital in End User Segment accounted for the largest share of the market with a revenue of 20.78 USD Billion
- The fastest growing segment Hearing Screen Test in Test Type Segment grew Fastest with a CAGR of 11.87% during the forecast period from 2024 to 2032.
RoMEA Newborn Screening Market Scope
RoMEA Newborn Screening Market Segmentation & Scope
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
Product Type
- Reagents and Assay Kits
- Instruments
End User
- Clinics
- Pediatric Clinics
- Hospital
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
RoMEA Newborn Screening Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 28.50 USD Billion |
| Market Value in 2032 | 54.28 USD Billion |
| CAGR (2025-2032) | 10.91% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Test Type,Product Type,End User,Disease Type,Technology |
Regional Insights:
-
Leading Market (2024-2032): RoMEA, leading in terms of revenue 28.50 USD Billion in 2024
- Key Country: RoMEA, leading in terms of revenue with value of 28.50 USD Billion in 2024.
Segments and Scope
-
RoMEA Newborn Screening Market to 2032, By Test Type
- Dried Blood Spot Test is the largest segment in RoMEA Newborn Screening Market to 2032 with a revenue of 14.51 USD Billion in the year 2024.
- Hearing Screen Test is the Fastest growing segment in RoMEA Newborn Screening Market to 2032 with a Growth rate of 10.58 % in forecast period 2025-2032.
-
RoMEA Newborn Screening Market to 2032, By Product Type
- Instruments is the largest segment in RoMEA Newborn Screening Market to 2032 with a revenue of 19.99 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in RoMEA Newborn Screening Market to 2032 with a Growth rate of 11.22 % in forecast period 2025-2032.
-
RoMEA Newborn Screening Market to 2032, By End User
- Hospital is the largest segment in RoMEA Newborn Screening Market to 2032 with a revenue of 20.78 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in RoMEA Newborn Screening Market to 2032 with a Growth rate of 11.17 % in forecast period 2025-2032.
-
RoMEA Newborn Screening Market to 2032, By Disease Type
- Critical Congenital Heart Diseases is the largest segment in RoMEA Newborn Screening Market to 2032 with a revenue of 18.85 USD Billion in the year 2024.
- Critical Congenital Heart Diseases is the Fastest growing segment in RoMEA Newborn Screening Market to 2032 with a Growth rate of 11.32 % in forecast period 2025-2032.
-
RoMEA Newborn Screening Market to 2032, By Technology
- Tandem Mass Spectrometry is the largest segment in RoMEA Newborn Screening Market to 2032 with a revenue of 8.08 USD Billion in the year 2024.
- Tandem Mass Spectrometry is the Fastest growing segment in RoMEA Newborn Screening Market to 2032 with a Growth rate of 11.63 % in forecast period 2025-2032.
RoMEA Newborn Screening Market Company Share Analysis
RoMEA Newborn Screening Market Geographical Sales Distribution, 2018-2032 USD Billion
RoMEA Newborn Screening Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoMEA Newborn Screening Market is segmented based on Segmentation Test Type,Product Type,End User,Disease Type,Technology.
RoMEA Newborn Screening Market was valued at USD 28.50(Revenue in USD Billion) in 2022.
RoMEA Newborn Screening Market is projected to grow at a CAGR of 10.91% during the forecast period of 2024 to 2032.
The Hospital segment is expected to dominate the RoMEA Newborn Screening Market , holding a largest market share of 20.78 USD Billion in 2024
RoMEA Newborn Screening Market Scope
RoMEA Newborn Screening Market Segmentation & Scope
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
Product Type
- Reagents and Assay Kits
- Instruments
End User
- Clinics
- Pediatric Clinics
- Hospital
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
Frequently Asked Questions
The RoMEA Newborn Screening Market is segmented based on Segmentation Test Type,Product Type,End User,Disease Type,Technology.
RoMEA Newborn Screening Market was valued at USD 28.50(Revenue in USD Billion) in 2022.
RoMEA Newborn Screening Market is projected to grow at a CAGR of 10.91% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Newborn Screening Market for final year is USD 54.28 (USD Billion).
RoMEA Newborn Screening Market Company Profiling
Frequently Asked Questions
The RoMEA Newborn Screening Market is segmented based on Segmentation Test Type,Product Type,End User,Disease Type,Technology.
RoMEA Newborn Screening Market was valued at USD 28.50(Revenue in USD Billion) in 2022.
RoMEA Newborn Screening Market is projected to grow at a CAGR of 10.91% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Newborn Screening Market for final year is USD 54.28 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.